`Acornea` expands clinical applications Completed FDA registration
(WorldNews China)

[Group News] China Regenerative Medicine International Limited (Stock Code: 8158.HK) "Acornea" expands clinical applications Completed FDA registration (25 July, 2017 - Hong Kong) - China Regenerative Medicine International Limited ("CRMI" or the "Company," stock code: 8158.HK, together with its subsidiaries, collectively the "Group") is pleased to announce that the Group has actively expanding the clinical applications of its bioengineered cornea "Acornea" in ophthalmological surgeries. Recently, U.S. Food and Drug Administration ("FDA") approves biomaterial of Acornea...